Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Market Cap	1.85B +128.2%
Revenue (ttm)	367.02M +33.3%
Net Income	46.50M
EPS	1.22
Shares Out	37.86M
PE Ratio	40.06
Forward PE	45.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,900
Average Volume	66,323
Open	48.06
Previous Close	48.96
Day's Range	47.10 - 49.04
52-Week Range	24.30 - 71.25
Beta	0.71
RSI	36.35
Earnings Date	Mar 25, 2026

About HKG:6609

Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid ar...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 327
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6609

Financial Performance

In 2024, HKG:6609's revenue was 277.90 million, an increase of 19.61% compared to the previous year's 232.34 million. Losses were -13.62 million, -85.51% less than in 2023.

Financial numbers in CNY